glutathione s-transferase class-mu 26 kda isozyme gst26

glutathione s-transferase class-mu 26 kda isozyme gst26 Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution Overexpression of Glutathione S-Transferases in

Name: glutathione s-transferase class-mu 26 kda isozyme gst26 Transferase P1-1 an Enzyme Useful in Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution Overexpression of Glutathione S-Transferases in
Brand: lcog.de
SKU: 86425829458
Price: 26.71 USD
Availability: InStock
Rating: 4.1530000000000005 (11 reviews)

Overexpression of Glutathione S Transferases in Human Diseases: Drug Targets and Therapeutic Implications Modulation of Glutathione S Transferase by Phytochemicals: To Activate or InhibitThat Is the Question Unveiling the Role of Glutathione S transferase Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications ACS Pharmacology & Translational Science Delta class glutathione S transferase (TuGSTd01) from the two spotted spider mite Tetranychus urticae is inhibited by abamectin ScienceDirect The role of glutathione S transferase in anti cancer drug resistance Oncogene

SKU: 86425829458 · From lcog.de

4.2

USD26.71 USD54.71

Pay in 4 interest-free payments of $6.68 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Vi hn 20 nm xy dng v pht trin, Allmax lun m bo cc sn phm ca mnh c cht lng cao nht v an ton tuyt i

Eat "prebiotic" fibres (like onions, garlic, and bananas) to feed beneficial bacteria and "probiotic" foods (like kefir or live yoghurt) to introduce them

Cysteine is generated from the essential amino acid methionine, from the degradation of dietary protein, or from turnover of endogenous proteins

Availability does not replace individualized judgment, and no single formulation is automatically appropriate for everyone

To better improve drug utilisation, the investigators further designed and synthesised the targeted ROS-responsive nanocarrier PCC-R8-ROS@miR-134-5p inhibitor (Lan et al., 2023), which more efficiently delivered the miR-134-5p inhibitor to the alveolar epithelial cells, providing a more efficient therapeutic strategy for BPD